This inventor holds 1 USPTO granted patent. Top assignee: Linc Invest Ab. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Cecilia Johnsson: Innovator in Inflammation Treatment
Introduction
Cecilia Johnsson is a notable inventor based in Uppsala, Sweden. She has made significant contributions to the field of medicine, particularly in the treatment of inflammation. Her innovative approach has led to the development of a unique application of hyaluronidase, a key enzyme in her research.
Latest Patents
Cecilia holds 1 patent for her work titled "Use of hyaluronidase in the manufacturing of a drug for the treatment of inflammation." This patent outlines the use of hyaluronidase in treating inflammation associated with increased local synthesis of hyaluronan in mammals. The treatment is particularly relevant in scenarios such as organ grafting, where hyaluronidase can be administered either locally or systemically to reduce inflammatory cell infiltration.
Career Highlights
Cecilia is currently associated with Linc Invest AB, where she continues to advance her research and development efforts. Her work has garnered attention for its potential to improve patient outcomes in inflammatory conditions.
Collaborations
Cecilia has collaborated with esteemed colleagues, including Roger Hällgren and Bengt Gerdin, to further her research initiatives. Their combined expertise has contributed to the success of her innovative projects.
Conclusion
Cecilia Johnsson's contributions to the field of inflammation treatment through her patent on hyaluronidase exemplify her dedication to medical innovation. Her work not only highlights her inventiveness but also the collaborative spirit of scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile